Hyperkalemia and acute kidney injury with spironolactone use among patients with heart failure

AM Secora, JI Shin, Y Qiao, GC Alexander… - Mayo Clinic …, 2020 - Elsevier
Objective To quantify the risk of hyperkalemia and acute kidney injury (AKI) when
spironolactone use is added on to loop diuretic use among patients with heart failure, and to …

[HTML][HTML] Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich …

A Dixit, G Majumdar, P Tewari - Annals of Cardiac Anaesthesia, 2019 - journals.lww.com
Conclusion: In India, many patients are from a low socioeconomic background and often
resort to cheap and filling food items like bananas. This dietary factor should be kept in mind …

Complete inhibition of the renin–angiotensin–aldosterone system; where do we stand?

SS Chen, SL Seliger, LF Fried - Current Opinion in Nephrology …, 2014 - journals.lww.com
Current evidence supports avoiding dual renin–angiotensin–aldosterone system blockade
in patients with chronic kidney disease. Subsequent studies of dual renin–angiotensin …

Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure

A Talatinian, SL Chow… - … : The Journal of Human …, 2012 - Wiley Online Library
Despite numerous pharmacologic and nonpharmacologic treatment strategies, heart failure
remains a complex, progressive disorder with significant morbidity and mortality …

Aldosterone antagonists in systolic heart failure

AJ Lindblad, GM Allan - Canadian Family Physician, 2014 - cfp.ca
• RALES1: an RCT of 1663 patients with class III or IV HF taking ACEIs and diuretics;
patients received spironolactone or placebo. Results at 24 months:-A statistically significant …

Current awareness: Pharmacoepidemiology and drug safety

John Wiley & Sons, Ltd. - 2003 - Wiley Online Library
In order to keep subscribers up‐to‐date with the latest developments in their field, John
Wiley & Sons are providing a current awareness service in each issue of the journal. The …

[PDF][PDF] THE EFFECT OF SPIRONOLACTONE ON SERUM ELECTROLYTES AND RENAL FUNCTION TESTS IN PATIENTS WITH SEVERE CHRONIC HEART …

SA Almedeny, JY Al-Mayah… - Wiadomosci lekarskie …, 2021 - researchgate.net
The aim: To evaluate the effect of single daily 25 mg of spironolactone on serum electrolytes
and kidney function tests in patients with severe chronic left sided heart failure. Materials …

Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer

J Slawik, J Dederer, I Kindermann… - ESC Heart Failure, 2020 - Wiley Online Library
Aims One prevalent comorbidity of chronic heart failure (CHF) is chronic kidney disease
(CKD). Hyperkalemia is associated with both CHF and CKD, which often leads to withdrawal …

14. Severe electrolyte disorders after overdosing of furosemide, spironolactone and captopril in infants with congenital heart defects: A case series

DTH Van, BTK Ngoc - Tạp chí Nghiên cứu Y học, 2022 - tapchinghiencuuyhoc.vn
Congenital heart defects are common congenital defects and they are major causes of death
in those with congenital malformation. 1, 2 Heart failure is a common complication thus all …

STUDIUM INTERAKCÍ LÉČIV S ENZYMY METABOLISMU CIZORODÝCH LÁTEK

K Krasulová - 2021 - dspace.cuni.cz
Cílem předložené disertační práce bylo zhodnotit interakce optických isomerů vybraných
chirálních léčiv s devíti formami nejdůležitějšího enzymatického aparátu metabolismu …